source
- Novo Nordisk lifts 2026 guidance as Wegovy sales surge in Q1Novo Nordisk reported its first‑quarter results, noting that sales and operating profit are expected to decline less than previously forecast. The company said adjusted sales fell between 4% and 1…
- GSK signs $1 billion siRNA partnership with China's SiranBio to target obesityGSK is expanding its cardiometabolic portfolio by entering a new collaboration with Chinese biotech SiranBio. The agreement is valued at $1 billion in biobucks and focuses on developing siRNA ther…